| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $60.3M | +122.0% |
| R&D Expense | $126.5M | -1.0% |
| SG&A Expense | $73.5M | +16.0% |
| Operating Income | -$139.7M | +14.8% |
| Pre-tax Income | -$112.5M | +30.9% |
| Income Tax | $1.3M | -46.5% |
| Net Income | -$113.9M | +31.2% |
| EPS (Basic) | -$0.09 | +47.1% |
| EPS (Diluted) | -$0.09 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.0M | +33.3% |
| Accounts Receivable | $821K | -89.0% |
| Current Assets | $207.6M | -18.7% |
| Total Assets | $282.6M | -14.1% |
| Current Liabilities | $72.8M | +12.8% |
| Total Liabilities | $243.1M | -1.6% |
| Stockholders' Equity | $39.5M | -51.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$140.9M | +0.6% |
| Capital Expenditures | $4.7M | -84.1% |
| Investing Cash Flow | $176.5M | +98.1% |
| Financing Cash Flow | $880K | -93.2% |
| Free Cash Flow | -$145.6M | +15.0% |
| +47.1% |